Streetbeat News

BIOE

Bio Essence Corp

Open

0.26

Mkt cap

10M

Volume

8.2K

High

0.27

P/E Ratio

-4.55

52-wk high

5.49

Low

0.25

Div yield

N/A

52-wk low

0.21

Insiders are buying shares of Expensify, Bio Essence, and Perspective Therapeutics, indicating confidence in these companies despite recent challenges. Expensify posted downbeat quarterly results, Bio Essence's stock surged 127% in the past month, and Perspective Therapeutics announced an $80 million underwritten offering.

Portfolio Pulse from Avi Kapoor

June 04, 2024 | 11:24 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.